Next, the response of Nrf2 and autophagy markers, including p62, ATG5-ATG12 complex, and LC3, to DMF02 treatment were evaluated in B16F0 melanoma cells and HaCaT keratinocytes. This evidence concerns the gene NFE2L2 and melanoma.